Synopsis of recent research by authors named "Yangyue Xu"
- Yangyue Xu's research primarily focuses on the mechanisms of tumor biology and therapeutic resistance, particularly in lung and gastric cancers, exploring the roles of histone deacetylase inhibitors and SUMOylation in enhancing antitumor immunity and promoting chemoresistance, respectively.
- Xu's studies highlight the significance of non-coding RNAs and epigenetic modifications, such as mA and FTO, in creating immunosuppressive tumor microenvironments and influencing the progression of gastric cancer.
- The research also covers clinical aspects of gastroenteropancreatic neuroendocrine carcinomas, aiming to improve understanding of treatment options and outcomes, thereby contributing to personalized cancer therapies.
